Read + Share
Joshi SK, Pittsenbarger J, Kennedy VE, Peretz CAC, et al. The FLT3(N701K) mutation causes clinical AML resistance to gilteritinib and
triggers TKI sensitivity switch to quizartinib. Am J Hematol 2023;98:E364-E368.
PMID: 37815132
|
 |
|
Joshi SK, Pittsenbarger J, Kennedy VE, Peretz CAC, et al. The FLT3(N701K) mutation causes clinical AML resistance to gilteritinib and
triggers TKI sensitivity switch to quizartinib. Am J Hematol 2023;98:E364-E368.
PMID: 37815132
|
|
|
|